Rockwell Medical (NASDAQ: RMTI) reported Q3 EPS of ($0.07), $0.04 better than the analyst estimate of ($0.11). Revenue for the quarter came in at $23.8 million versus the consensus estimate of $23.67 million.

For earnings history and earnings-related data on Rockwell Medical (RMTI) click here.